XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Statements of Cash Flows
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Cash Provided by (Used in) Operating Activities      
Net earnings $ 2,166 $ 6,070 $ 3,074
Adjustments to reconcile net earnings to operating cash flows:      
Depreciation and amortization   194 163
Deferred income tax provision (benefit)   (575) (550)
Unrecognized tax benefit   1,173 [1] 21
(Income) losses from investments in equity securities (58) (105) 3,707
Dividends from ABI   163 104
Loss on Cronos-related financial instruments 0 0 14
Cash effects of changes      
Receivables   19 [2] (5)
Inventories   26 [2] 88
Accounts payable   (47) [2] (27)
Income taxes   (210) [2] 49
Accrued liabilities and other current assets   (210) [2] (382)
Accrued settlement charges   (537) [2] (618)
Pension plan contributions   (14) (11)
Pension and postretirement, net   (97) (110)
Other, net   210 120
Net cash provided by (used in) operating activities   6,060 5,637 Close
Cash Provided by (Used in) Investing Activities      
Capital expenditures   (143) (147)
Proceeds from the sale of IQOS System commercialization rights   1,700 0
Acquisition of NJOY, net of cash acquired   (2,751) 0
Other, net   (23) (68)
Net cash provided by (used in) investing activities   (1,217) (215) Close
Cash Provided by (Used in) Financing Activities      
Proceeds from short-term borrowings   2,000 0
Repayment of short-term borrowings   (2,000) 0
Long-term debt repaid   (1,566) (1,105)
Repurchases of common stock   (732) (1,451)
Dividends paid on common stock   (5,040) (4,908)
Other, net   (15) (12)
Net cash provided by (used in) financing activities   (7,353) (7,476) Close
Cash, cash equivalents and restricted cash:      
Increase (decrease)   (2,510) (2,054)
Balance at beginning of period   4,091 4,594
Balance at end of period 1,581 1,581 2,540
Cash and cash equivalents 1,537 1,537  
Restricted cash included in other current assets 10 [3] 10 [3]  
Restricted cash included in other assets 34 [3] 34 [3]  
Cash, cash equivalents and restricted cash $ 1,581 $ 1,581 $ 2,540
[1] 2023 relates to unrecognized tax benefit from the ordinary loss for cash tax purposes with respect to a portion of our tax basis associated with our former investment in JUUL. For further discussion, see Note 12. Income Taxes.
[2] 2023 amounts are net of the effects from the NJOY Transaction. For further details, see Note 2. Acquisition of NJOY.
[3] Restricted cash consisted primarily of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 13. Contingencies.